SCZM
Santacruz Silver Mining Ltd. Common Shares
SCZM's fundamentals are strong: revenue grew 39% and its operating margin rose 6 points to 30%, though free cash flow fell 49%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SCZM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Stable | |
| Strong |
SCZM's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SCZM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $5.94 | -16% |
| Fair | 15x | $6.44 | -8.6% |
| Expensive | 16x | $6.93 | -1.7% |
| Current | 16x | $7.05 | — |
| Forward | 30x | $7.05 | — |
Historical ranges are pointers, not guarantees.
SCZM's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
SCZM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect SCZM's earnings to decline, with its revenue and profitability holding steady.
SCZM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.24 | -47% |
| Q2 2026 | $0.44 | -49% |
| Q1 2026 | $0.65 | -1.5% |
| Q4 2025 | $0.46 | -78% |
| Q3 2025 | $0.84 | -56% |
| Q2 2025 | $0.87 | -48% |
| Q1 2025 | $0.66 | -61% |
| Q4 2024 | $2.05 | +979% |
| Q3 2022 | -$0.29 | -$0.28 |
SCZM's earnings per share have fallen from their peak: $0.44 over the past year, against $2.05 in late 2024.
SCZM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $110.6M | +48% |
| Q1 2026 | $127.5M | +82% |
| Q4 2025 | $104.4M | +31% |
| Q3 2025 | $79.1M | +0.3% |
| Q2 2025 | $74.5M | +5.7% |
| Q1 2025 | $70.1M | +34% |
| Q4 2024 | $79.4M | +34% |
| Q3 2024 | $78.9M | +24% |
SCZM's revenue has grown year over year for nine quarters in a row: $111M last quarter, up 48% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 41% | +14 points |
| Q1 2026 | 27% | -5.9 points |
| Q4 2025 | 32% | +5.7 points |
| Q3 2025 | 16% | +4.7 points |
| Q2 2025 | 27% | +13 points |
| Q1 2025 | 33% | +41 points |
| Q4 2024 | 26% | +15 points |
| Q3 2024 | 11% | +12 points |
SCZM's operating margin was 41% last quarter, up 14 points from the same quarter a year ago, near the top of its range since 2019.
SCZM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $8.6M | -69% |
| Q1 2026 | -$1.1M | -$98K |
| Q4 2025 | $5.7M | -64% |
| Q3 2025 | $15.7M | +12% |
| Q2 2025 | $27.9M | +767% |
| Q1 2025 | -$986K | +$270.4K |
| Q4 2024 | $15.7M | +317% |
| Q3 2024 | $14.1M | +$17.8M |
SCZM generated $29M in free cash flow over the past year, down 49% from the year before.
SCZM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -39.1K shares |
| 1 year | +0.6% | +602K shares |
| 3 years | +4.4% | +4M shares |
| 5 years | +35% | +24.4M shares |
| Available history | +115% | +50.4M shares |
SCZM has 94M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
SCZM hasn't bought back shares in the past year.
SCZM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
| Q3 2024 | -0.0x | Net Cash |
SCZM has more cash than debt.
SCZM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.9 | Neutral |
| Stochastic | 18.5 | Oversold |
SCZM's weekly RSI is 55 (neutral) and its Stochastic is 18 (oversold).
SCZM PE vs Basic Materials Sector
| Metric | SCZM | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 19x | 14% below |
| PE % | 88 | 5 | 83 pts above |
SCZM is trading at 16x earnings, a 14% discount to the Basic Materials sector's median of 19x, though its earnings don't support one.
SCZM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.00 | 12% below |
| 20 week MA | $8.07 | 13% below |
SCZM is in a downtrend: it's below all two of its weekly moving averages, and 13% below its 20-week average.
SCZM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $11.6 | $7.05 | -39% |
It's down 39% so far in 2026.